Departments of Psychiatry and Neuroscience, University of Alberta, Edmonton, Alta.
To submit questions for this regular feature, please send them to the Journal of Psychiatry & Neuroscience, CMA Media Inc., 1867 Alta Vista Dr., Ottawa ON K1G 3Y6, Canada; fax 613 565-5471;[email protected]. Please include details of any relevant case and your name, address, telephone and fax numbers as well as your email address.
The information in this column is not intended as a definitive treatment strategy but as a suggested approach for clinicians treating patients with similar histories. Individual cases may vary and should be evaluated carefully before treatment is provided.
Competing interests: Dr. Silverstone has been a member of the advisory boards of AstraZeneca, Eli Lilly and Wyeth and has received speaker fees and travel assistance from these companies.
